Ateneo - UPO

Epidemiology, diagnosis, and treatment of the main solid tumors (breast, lung, colorectal, gynecological, and genitourinary cancers)
Treatment and management of oncological emergencies
Most common toxicities associated with cancer treatments

ASCo and ESMO guidelines

By the end of the course, participants should be able to:
- Describe the epidemiology and main risk factors of the most common solid tumors.
- Recognize the key clinical features and diagnostic pathways of breast, lung, colorectal, gynecological, and genitourinary cancers.
- Summarize the main principles of staging and treatment of the most common solid malignancies.
- Identify the major systemic anticancer treatment strategies, including chemotherapy, targeted therapies, immunotherapy, and endocrine therapy.
- Recognize the most common oncological emergencies and outline their initial assessment and management.
- Identify the most frequent toxicities associated with anticancer treatments and describe appropriate prevention, monitoring, and management strategies.
- Recognize clinical situations requiring urgent referral or multidisciplinary oncological evaluation.
- Apply basic principles of supportive care in patients receiving anticancer treatment.

Clinical examination, principles of general pathology, and principles of internal medicine.

Lectures supported by slides, combined with interactive teaching through the discussion of real clinical cases.

NA

Written examination

Introduction to oncology: principles of carcinogenesis, cancer epidemiology, assessment of the oncology patient (ECOG Performance Status), TNM staging, and the biological, clinical, and therapeutic differences between early-stage and metastatic cancers
Anticancer therapies, their toxicities, and mechanisms of resistance: chemotherapy, targeted therapies, immunotherapy, and antibody-drug conjugates
Oncological emergencies and infusion-related reactions
Breast cancer
Lung cancer
Gynecological cancers
Colorectal cancer
Prostate, kidney, and bladder cancers

By the end of the course, students should be able to:
- Explain the basic principles of carcinogenesis and cancer epidemiology.
- Describe the general clinical assessment of patients with cancer, including ECOG Performance Status and TNM staging.
- Distinguish the main biological, clinical, and therapeutic differences between early-stage and metastatic cancers.
- Describe the main classes of anticancer treatments, including chemotherapy, targeted therapies, immunotherapy, and antibody-drug conjugates.
- Recognize the most common toxicities associated with anticancer treatments and outline their basic management.
- Explain the main mechanisms of resistance to systemic anticancer therapies.
- Recognize the most relevant oncological emergencies and infusion-related reactions and describe their initial management.
- Describe the epidemiology, diagnostic work-up, staging, and main treatment strategies of breast, lung, colorectal, gynecological, prostate, kidney, and bladder cancers.
- Apply basic oncological principles to the discussion and interpretation of real clinical cases.
- Identify situations requiring urgent oncological assessment or multidisciplinary management.